Molecular Basis for Lytic Bacteriophage Resistance in Enterococci
ABSTRACT The human intestine harbors diverse communities of bacteria and bacteriophages. Given the specificity of phages for their bacterial hosts, there is growing interest in using phage therapies to combat the rising incidence of multidrug-resistant bacterial infections. A significant barrier to...
Enregistré dans:
Auteurs principaux: | Breck A. Duerkop, Wenwen Huo, Pooja Bhardwaj, Kelli L. Palmer, Lora V. Hooper |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/da554fd4d63c49bca75623e1ecb6509f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Multidrug-Resistant Enterococci Lack CRISPR-<italic toggle="yes">cas</italic>
par: Kelli L. Palmer, et autres
Publié: (2010) -
Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not Proven
par: Michael G. Jobling
Publié: (2021) -
Parallel Genomics Uncover Novel Enterococcal-Bacteriophage Interactions
par: Anushila Chatterjee, et autres
Publié: (2020) -
Reply to Jobling, “Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not Proven”
par: Leanid Laganenka, et autres
Publié: (2021) -
Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci
par: Benjamin P. Howden, et autres
Publié: (2013)